Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04482582 · ClinicalTrials.gov registry record · NA

Early Percutaneous Cryoablation for Pain Control After Rib Fractures Among Elderly Patients

A NA study, sponsored by Stanford University.

Completed
Registry status
NA
Development phase
127
Enrollment target

NCT04482582: Completed NA study, sponsored by Stanford University.

NCT04482582 is a NA study that has completed, run by Stanford University. The registered enrollment target is 127 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT04482582, a NA study, has completed, sponsored by Stanford University.

COMPLETED
Registry status
NA
Development phase
127 participants
Enrollment target

Study Summary

The purpose of this study is to provide long-term pain control for elderly patients with rib fractures in order to minimize their risk of complications and return them to baseline functional capacity

Primary Outcome

The patient will be asked to verbalize their numeric pain score on the day of hospital discharge. Pain is measured on a scale of 0 to 10, with 0 being no pain and 10 being the worst pain. Note: The timing of hospital discharge varies by patient as these are polytrauma patients.

Interventions

  • OTHER Standard of Care
  • RADIATION Cryoneurolysis

Trial Details

FieldValue
Enrollment Target 127 participants
Start Date 2021-06-01
Est. Completion 2025-04-30
Phase NA
Stanford University

1,744 total trials

What the finished NCT04482582 record still lists

NCT04482582 is an interventional study that assigns participants to a tested intervention. The registered 127 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).

The record links to 0 conditions, and to 2 interventions - of which Standard of Care is the first listed.

NCT04482582 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04482582 about?

NCT04482582 is a clinical study titled "Early Percutaneous Cryoablation for Pain Control After Rib Fractures Among Elderly Patients". The purpose of this study is to provide long-term pain control for elderly patients with rib fractures in order to minimize their risk of complications and return them to baseline functional capacity

What is the current status of trial NCT04482582?

This trial is currently completed. It is a NA study. The enrollment target is 127 participants. The study started on 2021-06-01. Estimated completion is 2025-04-30.

What interventions are being tested in trial NCT04482582?

The interventions under investigation include: Standard of Care (OTHER), Cryoneurolysis (RADIATION).

Who is sponsoring clinical trial NCT04482582?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04482582's enrollment target sits among peer trials

127 749th of 2000 higher than 1,252 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03017820 · 127 participants · Phase 1

    A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma

  • NCT03609580 · 127 participants · Phase 1

    Post-operative Urinary Retention (POUR) Following Thoracic Surgery

  • NCT06285643 · 127 participants · Phase 2

    A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD)

  • NCT06809400 · 127 participants · Phase 1

    A Study of LY4006896 in Healthy Participants and Participants With Parkinson's Disease

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04482582, the US trial registry maintained by the National Library of Medicine. NCT04482582 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.